ABSI Stock Analysis: Buy, Sell, or Hold?
ABSI - Absci Corporation Common Stock
$10.15
-0.46 (-4.29%)
▼
5d:
-12.09%
30d:
+59.01%
90d:
+240.44%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 11, 2026
28d
Get Alerted When ABSI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ABSI is down 12.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ABSI is down 12.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ABSI is currently trading at $10.14, which is considered slightly high relative to its 30-day fair value range of $6.97 to $11.08.
Technical Outlook: Technically, ABSI is in a strong uptrend. The price is currently testing key support at $10.10. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.3% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.78 (+30.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ABSI is in a strong uptrend. The price is currently testing key support at $10.10. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.3% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.78 (+30.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$6.97 -
$11.08
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.6%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.3%)
- BULLISH: Trading 30.0% below Wall St target ($13.78)
- WARNING: Recommendation downgraded due to -12.1% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$6.97 -
$11.08
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$10.10
Resistance Level
$12.06
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-17.03
Wall Street Target
$13.78
(+30.0%)
Revenue Growth (YoY)
-81.8%
Share & Embed Analysis
Last updated: July 13, 2026 3:32 PM ET
Data refreshes hourly during market hours. Next update: 4:32 PM
Data refreshes hourly during market hours. Next update: 4:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABSI showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
NEUTRAL
Recent Transactions
Andreas Busch
BUY
100000 shares
2026-03-12
Sean Mcclain
SELL
26761 shares
2026-02-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$413 | 54 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$822 | 64 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 55 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
